BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30516668)

  • 1. 18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases.
    Cuppari L; Reccia P; Burei M; Cervino AR; Evangelista L
    Clin Nucl Med; 2019 Feb; 44(2):e96-e97. PubMed ID: 30516668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain 18F-choline PET/CT in primary diffuse leptomeningeal melanomatosis.
    Jacob M; Delfort F; Heliette C; Renard D
    Acta Neurol Belg; 2016 Dec; 116(4):647-648. PubMed ID: 27085711
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracranial Leptomeningeal Carcinomatosis from Breast Cancer Detected on 18F-FDG PET.
    Carra BJ; Clemenshaw MN
    J Nucl Med Technol; 2015 Sep; 43(3):227-8. PubMed ID: 25655343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FES PET/CT for Characterization of Brain and Leptomeningeal Metastasis in Double Primary Cancer Patient.
    Lee Y; Yoo IR; Ha S
    Clin Nucl Med; 2022 Aug; 47(8):e554-e556. PubMed ID: 35797633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptomeningeal carcinomatosis: easy to miss.
    Sekhar A; Corbo B; Das K; Biswas S
    J R Coll Physicians Edinb; 2017 Dec; 47(4):351-352. PubMed ID: 29537406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptomeningeal Metastasis in Carotid Body Paraganglioma: Findings on 68Ga DOTANOC PET-CT.
    Tripathy S; Damle NA; Naranje P; Shamim SA; Tripathi M; Bal C
    Clin Nucl Med; 2019 Oct; 44(10):e583-e585. PubMed ID: 31348087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 68Ga-DOTATOC PET/CT and MR in the Evaluation of Meningeal Metastasis From Esthesioneuroblastoma: A Case Report.
    Dondi F; Albano D; Bertoli M; Bertagna F; Giubbini R
    Clin Nucl Med; 2021 Jul; 46(7):e378-e380. PubMed ID: 33782294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse cortical hypermetabolism of the cerebellum in meningeal carcinomatosis: Assessment with
    Crombé A; Cazeau AL; Cousin S; Chomy F; Bacci J; Kind M
    Diagn Interv Imaging; 2019 Dec; 100(12):821-823. PubMed ID: 31047839
    [No Abstract]   [Full Text] [Related]  

  • 9. Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis.
    Chen IC; Lin CH; Jan IS; Cheng AL; Lu YS
    J Formos Med Assoc; 2016 Apr; 115(4):243-8. PubMed ID: 25890495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 68Ga-FAPI PET/CT in Assessment of Leptomeningeal Metastases in a Patient With Lung Adenocarcinoma.
    Hao B; Wu J; Pang Y; Sun L; Chen H
    Clin Nucl Med; 2020 Oct; 45(10):784-786. PubMed ID: 32796242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leptomeningeal carcinomatosis following 27 years remission from breast cancer with epidermoid: a case report].
    Tajima Y; Horiguchi K; Nakano S; Hirono S; Higuchi Y; Oide T; Iwadate Y; Saeki N
    No Shinkei Geka; 2012 Apr; 40(4):343-9. PubMed ID: 22466234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI based neuroanatomical segmentation in breast cancer patients: leptomeningeal carcinomatosis vs. oligometastatic brain disease vs. multimetastastic brain disease.
    Mayinger M; Reibelt A; Borm KJ; Ettl J; Wilkens JJ; Combs SE; Oechsner M; Duma MN
    Radiat Oncol; 2019 Sep; 14(1):170. PubMed ID: 31533742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
    Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
    Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effective systemic palliative chemotherapy for intracranial metastases of breast cancer].
    Sipőcz I; Pintér T; Skaliczky Z; Kullmann T
    Orv Hetil; 2016 Nov; 157(45):1809-1813. PubMed ID: 27817234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Incidentally Detected by 18F-Choline PET/CT in a Patient With Recurrent Prostate Carcinoma.
    Vadrucci M; Gilardi L; Grana CM
    Clin Nucl Med; 2016 Nov; 41(11):892-893. PubMed ID: 27607157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis.
    Lee YC; Hsieh CC; Chuang JP; Li CY
    Curr Probl Cancer; 2017; 41(5):355-370. PubMed ID: 28779849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hashimoto's encephalopathy as the cause of deteriorating consciousness during treatment of leptomeningeal carcinomatosis from breast cancer.
    Liang YH; Wu PF; Lin CH; Lu YS
    J Clin Oncol; 2012 Nov; 30(33):e358-9. PubMed ID: 23045590
    [No Abstract]   [Full Text] [Related]  

  • 18. Leptomeningeal carcinomatosis can be presenting manifestation of breast carcinoma.
    Stojmenović GM; Pavlović AM; Gazibara MS; Grujicić D; Radojicić A; Sternić NC
    Vojnosanit Pregl; 2016 Mar; 73(3):293-5. PubMed ID: 27295918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.
    Salgia S; Fleming GF; Lukas RV
    J Clin Neurosci; 2014 Jul; 21(7):1250-1. PubMed ID: 24412296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis.
    Park WY; Kim HJ; Kim K; Bae SB; Lee N; Lee KT; Won JH; Park HS; Lee SC
    Cancer Res Treat; 2016 Apr; 48(2):843-7. PubMed ID: 25761487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.